PDK1 and hepatocellular carcinoma: PDK1 is highly expressed in hepatocellular carcinoma (HCC) and enhances the resistance of HCC cells to radiotherapy by activating PI3K signaling; promoting HCC cell migration, invasion, and EMT; and enhancing cancer cell stemness[10].